Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells.

Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells. Abstract Text:

    j liuJ Liu,k g suresh kumarK G Suresh Kumar,d yuD Yu,s a moltonS A Molton,m mcmahonM McMahon,m herlynM Herlyn,a thomas-tikhonenkoA Thomas-Tikhonenko,s y fuchsS Y Fuchs,

    Mutational activation of BRAF is a frequent event in human malignant melanomas suggesting that BRAF-dependent signaling is conducive to melanoma cell growth and survival. Previously published work reported that melanoma cells exhibit constitutive anti-apoptotic nuclear factor kappaB (NF-kappaB) transcription factor activation triggered by proteolysis of its inhibitor IkappaB. IkappaB degradation is dependent upon its phosphorylation by the IkappaB kinase (IKK) complex and subsequent ubiquitination facilitated by beta-Trcp E3 ubiquitin ligase. Here, we report that melanocytes expressing a conditionally oncogenic form of BRAF(V600E) exhibit enhanced beta-Trcp expression, increased IKK activity and a concomitant increase in the rate of IkappaBalpha degradation. Conversely, inhibition of BRAF signaling using either a broad-spectrum Raf inhibitor (BAY 43-9006) or by selective knock-down of BRAF(V600E) expression by RNA interference in human melanoma cells leads to decreased IKK activity and beta-Trcp expression, stabilization of IkappaB, inhibition of NF-kappaB transcriptional activity and sensitization of these cells to apoptosis. Taken together, these data support a model in which mutational activation of BRAF in human melanomas contributes to constitutive induction of NF-kappaB activity and to increased survival of melanoma cells.

    Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells. Publishing Authors By Initials

    j liuJ Liu,kg suresh kumarKG Suresh Kumar,d yuD Yu,sa moltonSA Molton,m mcmahonM McMahon,m herlynM Herlyn,a thomas-tikhonenkoA Thomas-Tikhonenko,sy fuchsSY Fuchs,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Oncogene

    VOLUME: 26

    Page Numbers: 1954-8

    Journal Abbreviation: Oncogene

    ISSN: 0950-9232

    DAY: 25

    MONTH: 09

    YEAR: 2006

    Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8711562

    Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells. Keywords Mesh Terms:

    KEYWORDS: beta-Transducin Repeat-Containing Protei

    MESH TERMS: genetics

    Chemical & Substance for Abstract: Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells. Information

    Substance Name: Proto-Oncogene Proteins B-raf

    Registry Number: EC 2.7.1.37

    Grant and Affiliation Information for Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells.

    AFFILIATION: Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104-6046, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NCI

    GRANT: R01 CA092900-06

    ACRONYM: CA

    MEDLINETA: Oncogene

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News